"The Board approved entering into a definitive Share Purchase Agreement (SPA) for the acquisition of 2,35,01,440 fully paid-up equity share...

The company last month had received Abbreviated New Drug Application approval from the US Food and Drug Administration (USFDA) for Aripipra...

In the last five trading sessions, Nifty Pharma index has rallied 9% as against 1% drop in the Nifty.

CLSA has retained buy rating on GAIL and sell rating on ONGC.

A total of 17,843 shares changed hands on the counter till 10:45AM (IST).

A total of 16,067 shares changed hands on the counter till 02:07PM (IST).

The Nifty 50 index was trading 62 points down at 8579.45.

Here's a look at the top stocks that are likely to hog limelight in today's trading session.

Hindustan Unilever, Idea Cellular and Bharti Infratel will announce their financial results for the quarter ended December 31, 2016 on Mond...

What made the market give up early gains to end in the red? Go through the top takeaways from the day before you head to the nearest wateri...

"There is lot of news flow driven moves that you continuously see in this space"

As per the European Commission Anti-trust ruling, Lupin has been fined 40 million euros, while Unichem Laboratories 13.96 million euros.

The national pharma price authority notified prices of 151 essential drugs on June 17.

We think Wyeth Lab would reward handsomely because we expect Wyeth to be amalgamated with Pfizer at a much higher valuation.

Ashit Suri, Fundamental Research Analyst, JV Capital Services, spoke to ET Now on pharma stocks prospects. Excerpts:

Sharmila Joshi of Emkay Global Financial Services in an interview with ET Now talks about steel and pharma stocks.

Sikkim, which is the least populous state in the country and the second-smallest after Goa, has already attracted pharma investment upwards...